On CNBC’s “Halftime Report Final Trades,” Joshua Brown, co-founder and CEO of Ritholtz Wealth Management, stated he stays lengthy on Apple Inc. (NASDAQ:AAPL).
Supporting his view, Wedbush analyst Dan Ives, on Tuesday, reiterated Apple with an Outperform ranking and maintained a $350 price target.
Jim Lebenthal, companion at Cerity Partners, stated AstraZeneca PLC (NYSE:AZN) is a excessive-high quality pharmaceutical inventory.
On the earnings entrance, AstraZeneca, on Feb. 10, reported fourth-quarter 2025 gross sales of $15.50 billion, up 4% yr over yr (+2% at fixed foreign money or cc), virtually consistent with the consensus of $15.49 billion. The adjusted earnings have been $2.12 per share, beating the consensus of $2.09.
Don’t neglect to take a look at our premarket coverage here
Jenny Van Leeuwen Harrington, chief government officer of Gilman Hill Asset Management, LLC, stated VICI Properties Inc. (NYSE:VICI) has a 6% dividend yield.
On Feb. 2, Scotiabank analyst Nicholas Yulico downgraded VICI Properties from Sector Outperform to Sector Perform and lowered the value goal from $36 to $30.
Joe Terranova, senior managing director for Virtus Investment Partners, named Ulta Beauty, Inc. (NASDAQ:ULTA) as his last commerce.
According to current information, Ulta Beauty introduced on Jan. 23 its first retailer opening within the United Arab Emirates. The cosmetics and skincare big stated it is going to debut at Mall of the Emirates on Jan. 29, in partnership with Alshaya Group.
Price Action:
- Apple shares gained 3.2% to shut at $263.88 on Tuesday.
- AstraZeneca shares rose 1.9% to shut at $209.48 throughout the session.
- VICI Properties shares gained 1.9% to settle at $29.86 on Tuesday.
- Ulta Beauty shares gained 3.4% to shut at $706.82 throughout the session.
Photo: Shutterstock
Market News and Data brought to you by Benzinga APIs
© 2026 Benzinga.com. Benzinga doesn’t present funding recommendation. All rights reserved.
To add Benzinga News as your most popular supply on Google, click here.